Heart Failure: Pharmacologic Management
May 2006, Wiley-Blackwell
This price is valid for United States. Change location to view local pricing and availability.
This is a Print-on-Demand title. It will be printed specifically to fill your order. Please allow an additional 5-6 days delivery time. The book is not returnable.
Other Available Formats: E-book
Initial chapters focus on agents that are considered standard care:
- ACE inhibitors
- angiotensin receptor antagonists
- aldosterone antagonists
The discussion moves to agents currently under investigation:
- Vasopressin antagonists
Next, the authors consider some controversial drugs:
- inotropic agents
- antiarrhythmic drugs
An insightful examination of pharmacogenetics considers:
- how studies of the genetic profile of patients helps determine which patient populations are most likely to respond to a given class of drugs
- the potential use of pharmacogenetics to tailor a pharmacologic regimen for maximum benefit and minimum risk
Multidrug pharmacy for heart failure therapy
An extremely helpful concluding chapter provides a roadmap of drugs with which to approach the patient with heart failure, along with an overview of the skills you need to use it most effectively. This straightforward, step-by-step algorithm will save you countless hours of research and help you make your prescribing decisions with confidence.